Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM4 | P08173 | 3/20 | 0.49 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | PPARA | Q07869 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | MET | P08581 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3402105 | 0.94 | CHRM4 (0.47) | CHRM4GAASMN1; SMN2HPGDLMNA | |
| SCHEMBL3401053 | 0.94 | CHRM4 (0.47) | CHRM4GAASMN1; SMN2HPGDLMNA | |
| SCHEMBL3399475 | 0.92 | CHRM4 (0.51) | CHRM4SCN9AGAASMN1; SMN2TSHR | |
| SCHEMBL3400096 | 0.91 | CHRM4 (0.49) | CHRM4SCN9AGAASMN1; SMN2TSHR | |
| SCHEMBL3399568 | 0.91 | CHRM4 (0.51) | CHRM4SCN9AGAASMN1; SMN2PPARA | |
| SCHEMBL3406027 | 0.90 | CHRM4 (0.50) | CHRM4SCN9AGAASMN1; SMN2PPARA | |
| SCHEMBL3400929 | 0.90 | SCN9A (0.49) | CHRM4SCN9AGAASMN1; SMN2TSHR | |
| SCHEMBL3402155 | 0.87 | CD274 (0.55) | CHRM4SCN9ASMN1; SMN2NPC1LMNA | |
| SCHEMBL3402417 | 0.87 | CHRM4 (0.49) | CHRM4GAASMN1; SMN2PPARAHPGD | |
| SCHEMBL3403817 | 0.86 | CHRM4 (0.49) | CHRM4GAASMN1; SMN2PPARAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7728009-B1 | Thiazole amides, imidazole amides and related analogues | NEUROGEN CORPORATION (US) | 2010-06-01 | — | — | US | disclosed |
| US-7728009-B1 | Thiazole amides, imidazole amides and related analogues | NEUROGEN CORPORATION (US) | 2010-06-01 | — | — | US | disclosed |
| US-7728009-B1 | Thiazole amides, imidazole amides and related analogues | NEUROGEN CORPORATION (US) | 2010-06-01 | — | — | US | disclosed |
| WO-2006089076-A9 | THIAZOLE AMIDES, IMIDAZOLE AMIDES AND RELATED ANALOGUES | NEUROGEN CORP (US) | 2007-04-26 | — | — | WO | disclosed |